Paul F. Dellaripa, MD Harvard Medical School, USA
Associate Physician, BWH
Assistant Professor of Medicine, HMS
1989 Intern in Medicine, New England Deaconess Hospital, Boston MA.
1990-92 Resident in Medicine, New England Deaconess Hospital
1992-94 Fellowship in Rheumatology, Tufts New England Medical Center
1995-96 Fellowship in Critical Care Medicine, Lahey Clinic, Burlington, MA and New England Deaconess Hospital
1995 Affiliate Staff, Deaconess Waltham Hospital ICU Physician, Waltham, MA
1996-2006 Staff Physician, Lahey Clinic, Rheumatology and Critical Care Medicine
2000-2006 Associate Program Director, Internal Medical Residency Program, Lahey Clinic
2000-02 Medical Director, Advanced Cardiac Life Support Program, Lahey Clinic
2002-2006 Chairman, Department of Rheumatology, Lahey Clinic
2008 Assistant Director, STRATUS Simulation Center, BWH
2008 Founder and Co-Director , Interstitial Lung Disease Clinic, BWH
1996-2001 Outstanding Teacher in Medicine Clerkship,Tufts University School of Medicine
2001 Excellence in Teaching Award, Lahey Clinic
2008 Excellence in teaching award, Rheumatology teaching module, HMS year II,Harvard Medical School
Mayo Clinic/Genentech (Dellaripa PI) 12/1/08-12/31/09
Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia.
Our overall research objective is to examine the course of patients with progressive RA-associated interstitial pneumonia treated with rituximab to gain important information on the usefulness of potential study endpoints, the magnitude of response that can be expected in a clinical trial and potential difficulties that can be associated with a certain trial design and the overall feasibility of a full-scale randomized controlled trial.